{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:58:50Z","timestamp":1790384330315,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gastric Cancer"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s10120-025-01665-z","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T01:51:40Z","timestamp":1758851500000},"page":"1114-1124","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Classification based on tumor phenotypes enables the novel molecular characterization of esophagogastric junction cancer"],"prefix":"10.1007","volume":"28","author":[{"given":"Kyota","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Hatakeyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2967-8267","authenticated-orcid":false,"given":"Masanori","family":"Terashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Nagashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Urakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Ohshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Ochiai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadakazu","family":"Shimoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Koseki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichiro","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Fujiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Tanizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Tsubosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etsuro","family":"Bando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yae","family":"Kanai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuto","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"key":"1665_CR1","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1093\/jnci\/djn211","volume":"100","author":"LM Brown","year":"2008","unstructured":"Brown LM, Devesa SS, Chow WH. Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst. 2008;100:1184\u20137.","journal-title":"J Natl Cancer Inst"},{"key":"1665_CR2","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1016\/j.ejca.2012.01.009","volume":"48","author":"JL Dikken","year":"2012","unstructured":"Dikken JL, Lemmens VE, Wouters MW, Wijnhoven BP, Siersema PD, Nieuwenhuijzen GA, et al. Increased incidence and survival for oesophageal cancer but not for gastric cardia cancer in the Netherlands. Eur J Cancer. 2012;48:1624\u201332.","journal-title":"Eur J Cancer"},{"key":"1665_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10388-022-00950-5","volume":"20","author":"M Watanabe","year":"2023","unstructured":"Watanabe M, Toh Y, Ishihara R, Kono K, Matsubara H, Miyazaki T, et al. Comprehensive registry of esophageal cancer in Japan, 2015. Esophagus. 2023;20:1\u201328.","journal-title":"Esophagus"},{"key":"1665_CR4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s10120-016-0663-8","volume":"20","author":"H Yamashita","year":"2017","unstructured":"Yamashita H, Seto Y, Sano T, Makuuchi H, Ando N, Sasako M. Results of a nation-wide retrospective study of lymphadenectomy for esophagogastric junction carcinoma. Gastric Cancer. 2017;20:69\u201383.","journal-title":"Gastric Cancer"},{"key":"1665_CR5","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1111\/j.1440-1746.2008.05572.x","volume":"23","author":"C Kusano","year":"2008","unstructured":"Kusano C, Gotoda T, Khor CJ, Katai H, Kato H, Taniguchi H, et al. Changing trends in the proportion of adenocarcinoma of the esophagogastric junction in a large tertiary referral center in Japan. J Gastroenterol Hepatol. 2008;23:1662\u20135.","journal-title":"J Gastroenterol Hepatol"},{"key":"1665_CR6","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1046\/j.1365-2168.1998.00940.x","volume":"85","author":"JR Siewert","year":"1998","unstructured":"Siewert JR, Stein HJ. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg. 1998;85:1457\u20139.","journal-title":"Br J Surg"},{"key":"1665_CR7","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000001386","volume":"94","author":"K Liu","year":"2015","unstructured":"Liu K, Zhang W, Chen X, Chen X, Yang K, Zhang B, et al. Comparison on clinicopathological features and prognosis between esophagogastric junctional adenocarcinoma (Siewert II\/III types) and distal gastric adenocarcinoma: retrospective cohort study, a single institution, high volume experience in China. Medicine (Baltimore). 2015;94:e1386.","journal-title":"Medicine (Baltimore)"},{"key":"1665_CR8","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nature13480","volume":"513","author":"AJ Bass","year":"2014","unstructured":"Bass AJ, Thorsson V, Shmulevich I, Reynolds SM, Miller M, Bernard B, et al. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513:202\u20139.","journal-title":"Nature"},{"key":"1665_CR9","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1097\/SLA.0000000000004303","volume":"275","author":"YS Suh","year":"2022","unstructured":"Suh YS, Na D, Lee JS, Chae J, Kim E, Jang G, et al. Comprehensive molecular characterization of adenocarcinoma of the gastroesophageal junction between esophageal and gastric adenocarcinomas. Ann Surg. 2022;275:706\u201317.","journal-title":"Ann Surg"},{"key":"1665_CR10","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1440-1827.2007.02102.x","volume":"57","author":"S Nunobe","year":"2007","unstructured":"Nunobe S, Nakanishi Y, Taniguchi H, Sasako M, Sano T, Kato H, et al. Two distinct pathways of tumorigenesis of adenocarcinomas of the esophagogastric junction, related or unrelated to intestinal metaplasia. Pathol Int. 2007;57:315\u201321.","journal-title":"Pathol Int"},{"key":"1665_CR11","doi-asserted-by":"publisher","first-page":"407","DOI":"10.2220\/biomedres.35.407","volume":"35","author":"K Yamaguchi","year":"2014","unstructured":"Yamaguchi K, Urakami K, Ohshima K, Mochizuki T, Akiyama Y, Uesaka K, et al. Implementation of individualized medicine for cancer patients by multiomics-based analyses\u2014the Project HOPE\u2014. Biomed Res. 2014;35:407\u201312.","journal-title":"Biomed Res"},{"key":"1665_CR12","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1111\/cas.14290","volume":"111","author":"T Nagashima","year":"2020","unstructured":"Nagashima T, Yamaguchi K, Urakami K, Shimoda Y, Ohnami S, Ohshima K, et al. Japanese version of the cancer genome atlas, JCGA, established using fresh frozen tumors obtained from 5143 cancer patients. Cancer Sci. 2020;111:687\u201399.","journal-title":"Cancer Sci"},{"key":"1665_CR13","doi-asserted-by":"crossref","unstructured":"Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011;14:101\u201312.","DOI":"10.1007\/s10120-011-0041-5"},{"key":"1665_CR14","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s10120-021-01242-0","volume":"25","author":"K Furukawa","year":"2022","unstructured":"Furukawa K, Hatakeyama K, Terashima M, Nagashima T, Urakami K, Ohshima K, et al. Molecular classification of gastric cancer predicts survival in patients undergoing radical gastrectomy based on project HOPE. Gastric Cancer. 2022;25:138\u201348.","journal-title":"Gastric Cancer"},{"key":"1665_CR15","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nature13480","volume":"513","author":"Comprehensive molecular characterization of gastric adenocarcinoma","year":"2014","unstructured":"Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513:202\u20139.","journal-title":"Nature"},{"key":"1665_CR16","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13073-017-0484-3","volume":"9","author":"H Ichikawa","year":"2017","unstructured":"Ichikawa H, Nagahashi M, Shimada Y, Hanyu T, Ishikawa T, Kameyama H, et al. Actionable gene-based classification toward precision medicine in gastric cancer. Genome Med. 2017;9:93.","journal-title":"Genome Med"},{"key":"1665_CR17","unstructured":"Ajani JA IH, Sano T, et al. Stomach. In: MB A, editor. AJCC Cancer Staging Manual. 8th ed. New York: Springer-Verlag; 2016. p. 203\u201320."},{"issue":"26","key":"1665_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10120-020-01042-y","volume":"2023","author":"Japanese Gastric Cancer Treatment Guidelines","year":"2021","unstructured":"Japanese Gastric Cancer Treatment Guidelines. 6th edition. Gastric Cancer. 2021;2023(26):1\u201325.","journal-title":"Gastric Cancer"},{"key":"1665_CR19","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.1172\/JCI91190","volume":"127","author":"M Ayers","year":"2017","unstructured":"Ayers M, Lunceford J, Nebozhyn M, Murphy E, Loboda A, Kaufman DR, et al. IFN-\u03b3-related mrna profile predicts clinical response to PD-1 blockade. J Clin Invest. 2017;127:2930\u201340.","journal-title":"J Clin Invest"},{"key":"1665_CR20","doi-asserted-by":"publisher","first-page":"1397352","DOI":"10.3389\/fgene.2024.1397352","volume":"15","author":"HK Krishnamurthy","year":"2024","unstructured":"Krishnamurthy HK, Rajavelu I, Pereira M, Jayaraman V, Krishna K, Wang T, et al. Inside the genome: understanding genetic influences on oxidative stress. Front Genet. 2024;15:1397352.","journal-title":"Front Genet"},{"key":"1665_CR21","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/annonc\/mdu450","volume":"26","author":"R Salgado","year":"2015","unstructured":"Salgado R, Denkert C, Demaria S, Sirtaine N, Klauschen F, Pruneri G, et al. The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an international TILs working group 2014. Ann Oncol. 2015;26:259\u201371.","journal-title":"Ann Oncol"},{"key":"1665_CR22","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/path.5516","volume":"252","author":"Q Geng","year":"2020","unstructured":"Geng Q, Lao J, Zuo X, Chen S, Bei JX, Xu D. Identification of the distinct genomic features in gastroesophageal junction adenocarcinoma and its Siewert subtypes. J Pathol. 2020;252:263\u201373.","journal-title":"J Pathol"},{"key":"1665_CR23","doi-asserted-by":"publisher","first-page":"4250","DOI":"10.1038\/s41388-019-0702-0","volume":"38","author":"K Echizen","year":"2019","unstructured":"Echizen K, Horiuchi K, Aoki Y, Yamada Y, Minamoto T, Oshima H, et al. NF-\u03baB-induced NOX1 activation promotes gastric tumorigenesis through the expansion of SOX2-positive epithelial cells. Oncogene. 2019;38:4250\u201363.","journal-title":"Oncogene"},{"key":"1665_CR24","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1158\/0008-5472.CAN-15-1512","volume":"76","author":"JH Joo","year":"2016","unstructured":"Joo JH, Oh H, Kim M, An EJ, Kim R-K, Lee S-Y, et al. NADPH oxidase 1 activity and ROS generation are regulated by Grb2\/Cbl-mediated proteasomal degradation of NoxO1 in colon cancer cells. Cancer Res. 2016;76:855\u201365.","journal-title":"Cancer Res"},{"key":"1665_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032086","author":"T Pecchillo Cimmino","year":"2023","unstructured":"Pecchillo Cimmino T, Ammendola R, Cattaneo F, Esposito G. NOX dependent ROS generation and cell metabolism. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24032086.","journal-title":"Int J Mol Sci"},{"key":"1665_CR26","first-page":"4474","volume":"20","author":"HP Wang","year":"2016","unstructured":"Wang HP, Wang X, Gong LF, Chen WJ, Hao Z, Feng SW, et al. Nox1 promotes colon cancer cell metastasis via activation of the ADAM17 pathway. Eur Rev Med Pharmacol Sci. 2016;20:4474\u201381.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1665_CR27","doi-asserted-by":"publisher","first-page":"62559","DOI":"10.18632\/oncotarget.11537","volume":"7","author":"SH Jung","year":"2016","unstructured":"Jung SH, Kim SM, Lee CE. Mechanism of suppressors of cytokine signaling 1 inhibition of epithelial-mesenchymal transition signaling through ROS regulation in colon cancer cells: suppression of Src leading to thioredoxin up-regulation. Oncotarget. 2016;7:62559\u201371.","journal-title":"Oncotarget"},{"key":"1665_CR28","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.stem.2013.04.006","volume":"12","author":"KB Myant","year":"2013","unstructured":"Myant KB, Cammareri P, McGhee EJ, Ridgway RA, Huels DJ, Cordero JB, et al. ROS production and NF-\u03baB activation triggered by RAC1 facilitate WNT-driven intestinal stem cell proliferation and colorectal cancer initiation. Cell Stem Cell. 2013;12:761\u201373.","journal-title":"Cell Stem Cell"},{"key":"1665_CR29","doi-asserted-by":"publisher","DOI":"10.1080\/16583655.2023.2194231","author":"A Zulpa","year":"2023","unstructured":"Zulpa A, Muttiah B, Vellasamy K, Mariappan V, Vadivelu J. Dentatin triggers ROS-mediated apoptosis, G0\/G1 cell cycle arrest and release of Th1-related cytokines in colorectal carcinoma cells. J Taibah Univ Sci. 2023. https:\/\/doi.org\/10.1080\/16583655.2023.2194231.","journal-title":"J Taibah Univ Sci"},{"key":"1665_CR30","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1093\/jjco\/hyd078","volume":"30","author":"H Nakayama","year":"2000","unstructured":"Nakayama H, Kitayama J, Muto T, Nagawa H. Characterization of intracellular cytokine profile of CD4(+) T cells in peripheral blood and tumor-draining lymph nodes of patients with gastrointestinal cancer. Jpn J Clin Oncol. 2000;30:301\u20135.","journal-title":"Jpn J Clin Oncol"},{"key":"1665_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107929","volume":"99","author":"H Chen","year":"2021","unstructured":"Chen H, Jiang T, Lin F, Guan H, Zheng J, Liu Q, et al. PD-1 inhibitor combined with apatinib modulate the tumor microenvironment and potentiate anti-tumor effect in mice bearing gastric cancer. Int Immunopharmacol. 2021;99:107929.","journal-title":"Int Immunopharmacol"},{"key":"1665_CR32","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-000599","volume":"8","author":"C Bergamaschi","year":"2020","unstructured":"Bergamaschi C, Pandit H, Nagy BA, Stellas D, Jensen SM, Bear J, et al. Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-\u03b3, CXCL9 and CXCL10. J Immunother Cancer. 2020;8:e000599.","journal-title":"J Immunother Cancer"},{"key":"1665_CR33","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.4049\/jimmunol.170.5.2727","volume":"170","author":"WJ Murphy","year":"2003","unstructured":"Murphy WJ, Welniak L, Back T, Hixon J, Subleski J, Seki N, et al. Synergistic anti-tumor responses after administration of agonistic antibodies to CD40 and IL-2: coordination of dendritic and CD8+ cell responses 1. J Immunol. 2003;170:2727\u201333.","journal-title":"J Immunol"},{"key":"1665_CR34","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1007\/s12272-010-1111-7","volume":"33","author":"YJ Kim","year":"2010","unstructured":"Kim YJ, Lim J, Kang JS, Kim HM, Lee HK, Ryu HS, et al. Adoptive immunotherapy of human gastric cancer with ex vivo expanded T cells. Arch Pharm Res. 2010;33:1789\u201395.","journal-title":"Arch Pharm Res"},{"key":"1665_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24054663","author":"FZ Benssouina","year":"2023","unstructured":"Benssouina FZ, Parat F, Villard C, Leloup L, Garrouste F, Sabatier JM, et al. Overexpression of a novel Noxo1 mutant increases Ros production and Noxo1 relocalisation. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24054663.","journal-title":"Int J Mol Sci"},{"key":"1665_CR36","doi-asserted-by":"publisher","first-page":"103710","DOI":"10.18632\/oncotarget.21780","volume":"8","author":"M Chocry","year":"2017","unstructured":"Chocry M, Leloup L, Kovacic H. Reversion of resistance to oxaliplatin by inhibition of p38 MAPK in colorectal cancer cell lines: involvement of the calpain \/ Nox1 pathway. Oncotarget. 2017;8:103710\u201330.","journal-title":"Oncotarget"},{"key":"1665_CR37","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.canlet.2016.08.023","volume":"382","author":"Z Zhang","year":"2016","unstructured":"Zhang Z, Duan Q, Zhao H, Liu T, Wu H, Shen Q, et al. Gemcitabine treatment promotes pancreatic cancer stemness through the Nox\/ROS\/NF-\u03baB\/STAT3 signaling cascade. Cancer Lett. 2016;382:53\u201363.","journal-title":"Cancer Lett"},{"key":"1665_CR38","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1089\/ars.2009.3078","volume":"13","author":"R Ven\u00e9","year":"2010","unstructured":"Ven\u00e9 R, Delfino L, Castellani P, Balza E, Bertolotti M, Sitia R, et al. Redox remodeling allows and controls B-cell activation and differentiation. Antioxid Redox Signal. 2010;13:1145\u201355.","journal-title":"Antioxid Redox Signal"},{"key":"1665_CR39","doi-asserted-by":"publisher","first-page":"1824632","DOI":"10.1080\/2162402X.2020.1824632","volume":"9","author":"M P\u00f6tzsch","year":"2020","unstructured":"P\u00f6tzsch M, Berg E, Hummel M, Stein U, von Winterfeld M, J\u00f6hrens K, et al. Better prognosis of gastric cancer patients with high levels of tumor infiltrating lymphocytes is counteracted by PD-1 expression. Oncoimmunology. 2020;9:1824632.","journal-title":"Oncoimmunology"},{"key":"1665_CR40","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1016\/j.molonc.2016.09.004","volume":"10","author":"C Dai","year":"2016","unstructured":"Dai C, Geng R, Wang C, Wong A, Qing M, Hu J, et al. Concordance of immune checkpoints within tumor immune contexture and their prognostic significance in gastric cancer. Mol Oncol. 2016;10:1551\u20138.","journal-title":"Mol Oncol"},{"key":"1665_CR41","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1111\/cas.14422","volume":"111","author":"S Suzuki","year":"2020","unstructured":"Suzuki S, Ogawa T, Sano R, Takahara T, Inukai D, Akira S, et al. Immune-checkpoint molecules on regulatory T-cells as a potential therapeutic target in head and neck squamous cell cancers. Cancer Sci. 2020;111:1943\u201357.","journal-title":"Cancer Sci"},{"key":"1665_CR42","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1007\/s10120-020-01056-6","volume":"23","author":"K Nakamura","year":"2020","unstructured":"Nakamura K, Hatakeyama K, Furukawa K, Fujiya K, Kamiya S, Hikage M, et al. Prediction of S-1 adjuvant chemotherapy benefit in stage II\/III gastric cancer treatment based on comprehensive gene expression analysis. Gastric Cancer. 2020;23:648\u201358.","journal-title":"Gastric Cancer"},{"key":"1665_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0233208","volume":"15","author":"J Lu","year":"2020","unstructured":"Lu J, Jiang G, Wu Y, Antony S, Meitzler JL, Juhasz A, et al. NADPH oxidase 1 is highly expressed in human large and small bowel cancers. PLoS ONE. 2020;15:e0233208.","journal-title":"PLoS ONE"},{"key":"1665_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.arres.2023.100080","author":"DJ Lagal","year":"2023","unstructured":"Lagal DJ, B\u00e1rcena JA, Requejo-Aguilar R, Padilla CA, Leto TL. NOX1 and PRDX6 synergistically support migration and invasiveness of hepatocellular carcinoma cells through enhanced NADPH oxidase activity. Adv Redox Res. 2023. https:\/\/doi.org\/10.1016\/j.arres.2023.100080.","journal-title":"Adv Redox Res"},{"key":"1665_CR45","doi-asserted-by":"crossref","unstructured":"de Vasconcelos ESA, de Faria CC, Pereira LM, Ferreira ACF, Torres PHM, Fortunato RS. Gene Expression and Prognostic Value of NADPH Oxidase Enzymes in Breast Cancer. Int J Mol Sci. 2024;25:","DOI":"10.3390\/ijms25063464"},{"key":"1665_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13205037","author":"MA Sorolla","year":"2021","unstructured":"Sorolla MA, Hidalgo I, Sorolla A, Montal R, Pallis\u00e9 O, Salud A, et al. Microenvironmental reactive oxygen species in colorectal cancer: involved processes and therapeutic opportunities. Cancers (Basel). 2021. https:\/\/doi.org\/10.3390\/cancers13205037.","journal-title":"Cancers (Basel)"},{"key":"1665_CR47","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.freeradbiomed.2007.10.035","volume":"44","author":"AJ Valente","year":"2008","unstructured":"Valente AJ, Zhou Q, Lu Z, He W, Qiang M, Ma W, et al. Regulation of NOX1 expression by GATA, HNF-1alpha, and Cdx transcription factors. Free Radic Biol Med. 2008;44:430\u201343.","journal-title":"Free Radic Biol Med"},{"key":"1665_CR48","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/jcmm.17649","volume":"27","author":"VJ Thannickal","year":"2023","unstructured":"Thannickal VJ, Jandeleit-Dahm K, Szyndralewiez C, T\u00f6r\u00f6k NJ. Pre-clinical evidence of a dual NADPH oxidase 1\/4 inhibitor (setanaxib) in liver, kidney and lung fibrosis. J Cell Mol Med. 2023;27:471\u201381.","journal-title":"J Cell Mol Med"},{"key":"1665_CR49","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/jso.24513","volume":"115","author":"K Polom","year":"2017","unstructured":"Polom K, Marrelli D, Roviello G, Pascale V, Voglino C, Rho H, et al. Molecular key to understand the gastric cancer biology in elderly patients-the role of microsatellite instability. J Surg Oncol. 2017;115:344\u201350.","journal-title":"J Surg Oncol"},{"key":"1665_CR50","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1007\/s10120-024-01506-5","volume":"27","author":"K Furukawa","year":"2024","unstructured":"Furukawa K, Hatakeyama K, Terashima M, Urakami K, Koseki Y, Fujiya K, et al. Molecular features and prognostic factors of locally advanced microsatellite instability-high gastric cancer. Gastric Cancer. 2024;27:760\u201371.","journal-title":"Gastric Cancer"}],"container-title":["Gastric Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-025-01665-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10120-025-01665-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-025-01665-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:03:26Z","timestamp":1790381006000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10120-025-01665-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["1665"],"URL":"https:\/\/doi.org\/10.1007\/s10120-025-01665-z","relation":{},"ISSN":["1436-3291","1436-3305"],"issn-type":[{"value":"1436-3291","type":"print"},{"value":"1436-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"21 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"MT has received honorarium from Taiho Pharmaceutical Co. Ltd., Chugai Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd., Bristol Myers Squib Japan K.K., Yakult Honsha Co., Ltd, Takeda Pharmaceutical Co., Ltd, Eli Lilly Japan K.K., Pfizer Japan Inc., Daiichi Sankyo Ltd., Johnson and Johnson K.K., Medtronic Japan Co., Ltd., Intuitive Japan Inc., and Olympus Co., Ltd. EB has received honorarium from Daiichi Sankyo Ltd.; Johnson and Johnson K.K.; Medtronic Japan Co., Ltd.; Intuitive Japan Inc.; Kaken Pharmaceutical; EIZO Corporation, TERUMO CORPORATION, and EIZAI Co.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures were conducted in accordance with the ethical standards of the corresponding committees on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions. The institutional review board at Shizuoka Cancer Center approved all aspects of this study (authorization number 25\u201333). Informed consent was obtained from all patients.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}